Portugal RD - Search Results

1

Risk factors for unsuccessful peripheral blood stem cell harvesting using granulocyte-colony stimulating factor mobilization in patients with multiple myeloma.

Lacativa CP, Lacativa PG, Garnica M, Portugal RD, Schaffel R, Dutra Hdos S, Nogueira CM, Nucci M, Maiolino A. Lacativa CP, et al. Among authors: portugal rd. Transfus Apher Sci. 2012 Dec;47(3):331-5. doi: 10.1016/j.transci.2012.06.013. Epub 2012 Aug 6. Transfus Apher Sci. 2012. PMID: 22874435

2

Strongyloidiasis in patients with hematologic malignancies.

Nucci M, Portugal R, Pulcheri W, Spector N, Ferreira SB, de Castro MB, Noe R, de Oliveira HP. Nucci M, et al. Clin Infect Dis. 1995 Sep;21(3):675-7. doi: 10.1093/clinids/21.3.675. Clin Infect Dis. 1995. PMID: 8527567

3

Clinical factors predictive of bone marrow involvement in Hodgkin's disease.

Spector N, Nucci M, Oliveira De Morais JC, Maiolino A, Portugal RD, Costa MA, Pulcheri W. Spector N, et al. Among authors: portugal rd. Leuk Lymphoma. 1997 Jun;26(1-2):171-6. doi: 10.3109/10428199709109172. Leuk Lymphoma. 1997. PMID: 9250802 Clinical Trial.

4

Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.

Nucci M, Biasoli I, Braggio S, Portugal R, Schaffel R, Maiolino A, Loureiro MM, Spector N, Pulcheri W. Nucci M, et al. Oncol Rep. 1998 Sep-Oct;5(5):1205-9. doi: 10.3892/or.5.5.1205. Oncol Rep. 1998. PMID: 9683836 Clinical Trial.

5

Resistance to activated protein C in thrombophilic patients in Rio de Janeiro.

Gadelha T, Portugal R, Nucci M, Spector N, Gouault-Heimann M. Gadelha T, et al. Acta Haematol. 1998;100(2):113. doi: 10.1159/000040881. Acta Haematol. 1998. PMID: 9792948 No abstract available.

6

Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies.

Schaffel R, Nucci M, Portugal R, Castro MB, Ferreira SB, Almeida L, Spector N, Pulcheri W. Schaffel R, et al. Clin Infect Dis. 2000 Sep;31(3):821-2. doi: 10.1086/314023. Clin Infect Dis. 2000. PMID: 11017840 Clinical Trial.

7

The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies.

Schaffel R, Nucci M, Carvalho E, Braga M, Almeida L, Portugal R, Pulcheri W. Schaffel R, et al. Am J Trop Med Hyg. 2001 Oct;65(4):346-50. doi: 10.4269/ajtmh.2001.65.346. Am J Trop Med Hyg. 2001. PMID: 11693882

8

Intensified ABVP chemotherapy for the primary treatment of Hodgkin's disease.

Spector N, Costa MA, Morais JC, Biasoli I, Solza C, De Fatima Gaui M, Ferreira CG, Portugal RD, Loureiro M, Nucci M, Pulcheri W. Spector N, et al. Among authors: portugal rd. Oncol Rep. 2002 Mar-Apr;9(2):439-42. Oncol Rep. 2002. PMID: 11836623

9

Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study.

Portugal R, Schaffel R, Almeida L, Spector N, Nucci M. Portugal R, et al. Haematologica. 2002 Jun;87(6):663-4. Haematologica. 2002. PMID: 12031927 Clinical Trial. No abstract available.

10

Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation.

Schaffel R, Portugal R, Maiolino A, Nucci M. Schaffel R, et al. Bone Marrow Transplant. 2004 Jan;33(1):117. doi: 10.1038/sj.bmt.1704309. Bone Marrow Transplant. 2004. PMID: 14704664 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters